000999 华润三九
已收盘 08-21 15:00:00
资讯
新帖
简况
研报掘金丨东方证券：维持华润三九“买入”评级，业绩有所承压，管线多点开花
格隆汇 · 08-20 09:26
研报掘金丨东方证券：维持华润三九“买入”评级，业绩有所承压，管线多点开花
华润三九股价微跌0.16% 上半年研发投入增长近七成
金融界 · 08-19 15:40
华润三九股价微跌0.16% 上半年研发投入增长近七成
华润三九：截至8月10日股东共78,438户
证券之星 · 08-19 08:27
华润三九：截至8月10日股东共78,438户
华润三九：公司设立“六院三室”研发体系
证券之星 · 08-19 08:27
华润三九：公司设立“六院三室”研发体系
华润三九：商誉减少因天士力可辨认资产和负债公允价值分配完成
证券之星 · 08-19 08:24
华润三九：商誉减少因天士力可辨认资产和负债公允价值分配完成
华润三九：鼓励天士力以创新驱动业务发展
证券之星 · 08-19 08:21
华润三九：鼓励天士力以创新驱动业务发展
中报“增收不增利”的华润三九：CHC业务“失速”，“三费”大增挤压利润，昆药集团营利双降“添堵”
证券之星 · 08-19 06:50
中报“增收不增利”的华润三九：CHC业务“失速”，“三费”大增挤压利润，昆药集团营利双降“添堵”
健康消费品业务失速叠加并购阵痛，华润三九上半年净利跌超两成
北京商报 · 08-17
健康消费品业务失速叠加并购阵痛，华润三九上半年净利跌超两成
国金证券：给予华润三九买入评级
证券之星 · 08-17
国金证券：给予华润三九买入评级
如何穿越周期？华润三九邱华伟：重塑规则，让合规成为翅膀
睿见Economy · 08-17
如何穿越周期？华润三九邱华伟：重塑规则，让合规成为翅膀
华润三九(000999)7月31日股东户数7.58万户，较上期增加5.18%
证券之星 · 08-16
华润三九(000999)7月31日股东户数7.58万户，较上期增加5.18%
图解华润三九中报：第二季度单季净利润同比减47.30%
证券之星 · 08-15
图解华润三九中报：第二季度单季净利润同比减47.30%
华润医药(03320.HK)：华润三九中期股东应占净利润18.15亿元，同比减少24.31%
智通财经 · 08-15
华润医药(03320.HK)：华润三九中期股东应占净利润18.15亿元，同比减少24.31%
华润三九：上半年净利润18.2亿元，上年同期24.0亿元
格隆汇 · 08-15
华润三九：上半年净利润18.2亿元，上年同期24.0亿元
每周股票复盘：博瑞医药（688166）与华润三九合作推进BGM0504商业化
证券之星 · 08-09
每周股票复盘：博瑞医药（688166）与华润三九合作推进BGM0504商业化
华润三九股价微涨0.09% 入选上市公司现金分红榜单
金融界 · 08-08
华润三九股价微涨0.09% 入选上市公司现金分红榜单
华润三九：公司围绕发展战略持续提升核心竞争力
证券之星 · 08-07
华润三九：公司围绕发展战略持续提升核心竞争力
7月以来股价翻倍，这家药企与华润三九合作布局减重药大单品丨机构调研
21世纪经济报道 · 08-07
7月以来股价翻倍，这家药企与华润三九合作布局减重药大单品丨机构调研
华润三九：公司已持有QHB-196项目的技术成果及知识产权
证券之星 · 08-06
华润三九：公司已持有QHB-196项目的技术成果及知识产权
华润三九：海外业务在公司总体业务中占比较小
证券之星 · 08-06
华润三九：海外业务在公司总体业务中占比较小
加载更多
公司概况
公司名称：
华润三九医药股份有限公司
所属行业：
医药制造业
上市日期：
2000-03-09
主营业务：
华润三九医药股份有限公司的主营业务是高质量医药健康产品创新研发和智能制造。公司的主要产品是CHC健康消费品、处方药。报告期内，公司获得中国质量协会QC成果发表赛一等奖。
发行价格：
8.45
{"stockData":{"symbol":"000999","market":"SZ","secType":"STK","nameCN":"华润三九","latestPrice":30.72,"timestamp":1755759804000,"preClose":30.36,"halted":0,"volume":22021115,"delay":0,"changeRate":0.0119,"floatShares":1662000000,"shares":1670000000,"eps":1.668,"marketStatus":"已收盘","change":0.36,"latestTime":"08-21 15:00:00","open":30.4,"high":30.91,"low":30.39,"amount":676000000,"amplitude":0.0171,"askPrice":30.73,"askSize":360,"bidPrice":30.72,"bidSize":823,"shortable":0,"etf":0,"ttmEps":1.668,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1755826200000},"marketStatusCode":5,"adr":0,"adjPreClose":30.36,"symbolType":"stock","openAndCloseTimeList":[[1755739800000,1755747000000],[1755752400000,1755759600000]],"highLimit":33.4,"lowLimit":27.32,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1669588290,"isCdr":false,"pbRate":2.38,"roa":"--","peRate":18.417266,"roe":"8.8%","epsLYR":2.63,"committee":0.60034,"marketValue":51290000000,"turnoverRate":0.0132,"status":0,"floatMarketCap":51058000000},"requestUrl":"/m/hq/s/000999","defaultTab":"news","newsList":[{"id":"2560617671","title":"研报掘金丨东方证券：维持华润三九“买入”评级，业绩有所承压，管线多点开花","url":"https://stock-news.laohu8.com/highlight/detail?id=2560617671","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560617671?lang=zh_cn&edition=full","pubTime":"2025-08-20 17:26","pubTimestamp":1755681991,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0010","600535","600958","BK0188","BK0185","03958","BK0196","BK0276","000999","BK0028","BK0012","BK0183","BK0060","BK0239","BK1564","BK0175","BK1147"],"gpt_icon":0},{"id":"2560113156","title":"华润三九股价微跌0.16% 上半年研发投入增长近七成","url":"https://stock-news.laohu8.com/highlight/detail?id=2560113156","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560113156?lang=zh_cn&edition=full","pubTime":"2025-08-19 23:40","pubTimestamp":1755618036,"startTime":"0","endTime":"0","summary":"华润三九股价报30.27元，较前一交易日下跌0.16%。华润三九属于医药制造业，主要从事医药产品的研发、生产、销售及相关健康服务。公司上半年实现营业收入148.10亿元，同比增长4.99%。研发投入达6.62亿元，同比增长68.99%。首个中药3.2类新药999益气清肺颗粒获批上市，28个重点研发项目中近半数进入临床III期。公司完成对天士力的收购后，新增19.21亿元商誉，截至上半年末商誉总额达70.45亿元。8月19日主力资金净流出10945.64万元，近五日主力资金净流出55115.33万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/19234052549429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0028","BK0239","000999","BK0188","BK0010","BK0183","BK0196","BK0012","BK0060","BK0175","BK0185"],"gpt_icon":0},{"id":"2560611169","title":"华润三九：截至8月10日股东共78,438户","url":"https://stock-news.laohu8.com/highlight/detail?id=2560611169","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560611169?lang=zh_cn&edition=full","pubTime":"2025-08-19 16:27","pubTimestamp":1755592049,"startTime":"0","endTime":"0","summary":"证券之星消息，华润三九(000999)08月19日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘：截止8月10日，股东人数是多少？华润三九回复：您好，截至8月10日，公司股东共78,438户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081900027559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","000999","BK0012","BK0185","BK0175","BK0183","BK0028","BK0196","BK0060","BK0010"],"gpt_icon":0},{"id":"2560980169","title":"华润三九：公司设立“六院三室”研发体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2560980169","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560980169?lang=zh_cn&edition=full","pubTime":"2025-08-19 16:27","pubTimestamp":1755592048,"startTime":"0","endTime":"0","summary":"证券之星消息，华润三九(000999)08月19日在投资者关系平台上答复投资者关心的问题。投资者提问：除了对外收购，公司有自己的创新药研发团队吗？公司对未来创新药研发有何布局和规划？华润三九回复：您好，公司设立“六院三室”研发体系，捕捉战略发展机遇，挖掘创新潜力，公司坚持创新驱动战略，自我诊疗领域以消费者需求为核心，聚焦优势品类，构建多元化产品矩阵；处方药领域以临床价值为导向，深耕“3+N”领域研发，围绕公司战略方向，构筑研发管线梯队。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081900027558.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0012","BK0188","BK0060","BK0196","BK0175","BK0185","BK0028","000999","BK0010","BK0239"],"gpt_icon":0},{"id":"2560169671","title":"华润三九：商誉减少因天士力可辨认资产和负债公允价值分配完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2560169671","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560169671?lang=zh_cn&edition=full","pubTime":"2025-08-19 16:24","pubTimestamp":1755591870,"startTime":"0","endTime":"0","summary":"华润三九回复：您好，公司在2025年第一季度报告中说明：鉴于合并成本在取得的天士力可辨认资产和负债的公允价值之间的分配工作尚未完成，在编制本报告期合并财务报表时，假设通过收购获得的天士力可辨认资产及负债的公允价值与账面价值一致，将交易对价与并表日天士力集团的资产及负债的账面价值份额之间的差额确认为商誉。截至半年度已完成可辨认资产和负债公允价值的分配。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081900027469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0010","600535","BK0185","BK0196","000999","BK0012","BK0060","BK0183","BK0028","BK0175"],"gpt_icon":0},{"id":"2560169562","title":"华润三九：鼓励天士力以创新驱动业务发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2560169562","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560169562?lang=zh_cn&edition=full","pubTime":"2025-08-19 16:21","pubTimestamp":1755591673,"startTime":"0","endTime":"0","summary":"华润三九回复：您好，未来公司会继续鼓励天士力以创新驱动业务发展，强化研发投入，推动研发效率提升，方向上聚焦心血管与代谢、神经/精神、消化等重要领域，丰富研发管线，提升研发能力，进一步巩固创新领先地位，并不断拓展新的业务领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081900027169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0060","600535","BK0175","BK0196","BK0183","BK0012","BK0185","BK0239","BK0010","000999"],"gpt_icon":0},{"id":"2560168937","title":"中报“增收不增利”的华润三九：CHC业务“失速”，“三费”大增挤压利润，昆药集团营利双降“添堵”","url":"https://stock-news.laohu8.com/highlight/detail?id=2560168937","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560168937?lang=zh_cn&edition=full","pubTime":"2025-08-19 14:50","pubTimestamp":1755586250,"startTime":"0","endTime":"0","summary":"这是华润三九2021年以来首次出现半年度净利润下滑。华润三九表示，净利润有所下降主要由于2024年上半年高基数的影响。证券之星注意到，华润三九费用开支的增加也挤压利润空间。由于CHC业务大幅下滑，拉低整体增速。需要注意的是，被华润三九收购后，昆药集团的营收近乎原地踏步。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025081900020042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0183","BK0010","000999","BK0175","BK0196","BK0188","BK0012","BK0239","600422","BK0060","BK0185"],"gpt_icon":0},{"id":"2560341927","title":"健康消费品业务失速叠加并购阵痛，华润三九上半年净利跌超两成","url":"https://stock-news.laohu8.com/highlight/detail?id=2560341927","media":"北京商报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560341927?lang=zh_cn&edition=full","pubTime":"2025-08-17 20:37","pubTimestamp":1755434220,"startTime":"0","endTime":"0","summary":"8月15日，华润三九发布完成收购天士力28%股权后的首份半年报。财报显示，华润三九上半年实现营业收入148.1亿元，同比增长4.99%；但归属于上市公司股东的净利润18.15亿元，同比下滑24.31%，扣非后净利润跌幅更达26.46%。并购天士力后的整合及相关投入，也成为影响华润三九利润的重要因素。而华润三九因收购昆药集团，商誉账面价值截至2025年上半年达11.29亿元。若未来天士力业绩未达预期或市场环境恶化，商誉减值风险将进一步冲击华润三九的利润。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-08-17/doc-infmiaaz4325178.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-08-17/doc-infmiaaz4325178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0010","BK0060","BK0185","BK0183","000999","BK0175","BK0196","BK0239","BK0188","BK0028","BK0012"],"gpt_icon":0},{"id":"2560784924","title":"国金证券：给予华润三九买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2560784924","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560784924?lang=zh_cn&edition=full","pubTime":"2025-08-17 18:00","pubTimestamp":1755424856,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,王奔奔近期对华润三九进行研究并发布了研究报告《业绩短期承压，产品管线持续扩充》，给予华润三九买入评级。按旧口径统计，1H25公司CHC业务实现收入约60.8亿元，同比-18.4%，同比下滑可能与上半年受流感等呼吸道疾病发病率同比降低、零售渠道阶段性调整等因素有关。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级5家，增持评级1家；过去90天内机构目标均价为42.08。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700010176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000999"],"gpt_icon":0},{"id":"2560501929","title":"如何穿越周期？华润三九邱华伟：重塑规则，让合规成为翅膀","url":"https://stock-news.laohu8.com/highlight/detail?id=2560501929","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560501929?lang=zh_cn&edition=full","pubTime":"2025-08-17 09:50","pubTimestamp":1755395400,"startTime":"0","endTime":"0","summary":" 8月17日上午消息，第十八届健康产业（国际）生态大会于8月16日至21日在海南博鳌举行。在开幕式上，华润三九医药股份有限公司董事长邱华伟致辞。 邱华伟表示，当AI压缩90%的研发周期，当银发经济释放万亿需求，破局关键是把老龄化包袱转化为全生命周期的解决方案，我们必须从被动适应者进化为主动定义者。 邱华伟指出，我们要构建穿越周期的三大支柱。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2025-08-17/doc-infmfyrm1123352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0239","000999","BK0012","BK0185","BK0175","BK0183","BK0028","BK0196","BK0060","BK0010"],"gpt_icon":0},{"id":"2559940108","title":"华润三九(000999)7月31日股东户数7.58万户，较上期增加5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559940108","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559940108?lang=zh_cn&edition=full","pubTime":"2025-08-16 17:03","pubTimestamp":1755335009,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华润三九披露，截至2025年7月31日公司股东户数为7.58万户，较7月20日增加3732.0户，增幅为5.18%。户均持股数量由上期的2.32万股减少至2.2万股，户均持股市值为69.02万元。在中药行业个股中，华润三九股东户数高于行业平均水平，截至7月31日，中药行业平均股东户数为5.43万户。根据统计，华润三九2025年7月20日至2025年7月31日，主力资金净流入8299.1万元，游资资金净流出2566.96万元，散户资金净流出5732.14万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081600015408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0010","BK0183","BK0060","BK0028","BK0196","BK0175","BK0188","BK0185","000999","BK0012"],"gpt_icon":0},{"id":"2559943817","title":"图解华润三九中报：第二季度单季净利润同比减47.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559943817","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559943817?lang=zh_cn&edition=full","pubTime":"2025-08-16 01:35","pubTimestamp":1755279332,"startTime":"0","endTime":"0","summary":"证券之星消息，华润三九2025年中报显示，公司主营收入148.1亿元，同比上升4.99%；归母净利润18.15亿元，同比下降24.31%；扣非净利润16.98亿元，同比下降26.46%；其中2025年第二季度，公司单季度主营收入79.57亿元，同比上升16.8%；单季度归母净利润5.45亿元，同比下降47.3%；单季度扣非净利润4.79亿元，同比下降51.11%；负债率34.19%，投资收益-3956.89万元，财务费用736.61万元，毛利率53.54%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081600000877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000999"],"gpt_icon":0},{"id":"2559919078","title":"华润医药(03320.HK)：华润三九中期股东应占净利润18.15亿元，同比减少24.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559919078","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559919078?lang=zh_cn&edition=full","pubTime":"2025-08-15 19:52","pubTimestamp":1755258721,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0010","BK0175","BK0185","MUCmain","BK0196","CYB","MCNHmain","UCmain","BK0028","03320","BK0239","000999","BK0188","BK0060","CNHmain","BK0183","BK1570","BK0012","BK1191"],"gpt_icon":0},{"id":"2559169179","title":"华润三九：上半年净利润18.2亿元，上年同期24.0亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559169179","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559169179?lang=zh_cn&edition=full","pubTime":"2025-08-15 18:46","pubTimestamp":1755254818,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0188","BK0028","BK0185","BK0196","BK0239","BK0010","000999","BK0060","BK0012","BK0175","BK0183"],"gpt_icon":0},{"id":"2558502082","title":"每周股票复盘：博瑞医药（688166）与华润三九合作推进BGM0504商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2558502082","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558502082?lang=zh_cn&edition=full","pubTime":"2025-08-10 01:16","pubTimestamp":1754759773,"startTime":"0","endTime":"0","summary":"截至2025年8月8日收盘，博瑞医药报收于114.83元，较上周的99.25元上涨15.7%。华润三九承担82亿研发里程碑和未来新适应症销售里程碑，表明其对BGM0504的产品力看好，双方将通过更多临床试验展现产品的优势和差异化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081000000057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0012","BK0239","000999","688166","BK0196","BK0183","BK0060","BK0010","BK0185","BK0175","BK0028"],"gpt_icon":0},{"id":"2558576474","title":"华润三九股价微涨0.09% 入选上市公司现金分红榜单","url":"https://stock-news.laohu8.com/highlight/detail?id=2558576474","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558576474?lang=zh_cn&edition=full","pubTime":"2025-08-09 00:55","pubTimestamp":1754672120,"startTime":"0","endTime":"0","summary":"华润三九最新股价报31.66元，较前一交易日上涨0.03元。盘中最高触及31.82元，最低下探至31.51元，成交量为90049手，成交金额达2.85亿元。公司主营业务涵盖医药产品研发、生产和销售，主要产品包括处方药、OTC药品及健康产品。作为医药行业的重要企业，华润三九入选了中国上市公司协会最新发布的2025年上市公司现金分红榜单。该榜单综合考量上市公司分红金额和分红比例，注重分红连续性、稳定性等指标。风险提示：股市有风险，投资需谨慎。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/09005552315115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000999","BK0196","BK0012","BK0239","BK0060","BK0028","BK0010","BK0183","BK0175","BK0185","BK0188"],"gpt_icon":0},{"id":"2557604565","title":"华润三九：公司围绕发展战略持续提升核心竞争力","url":"https://stock-news.laohu8.com/highlight/detail?id=2557604565","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557604565?lang=zh_cn&edition=full","pubTime":"2025-08-07 20:51","pubTimestamp":1754571095,"startTime":"0","endTime":"0","summary":"证券之星消息，华润三九(000999)08月06日在投资者关系平台上答复投资者关心的问题。投资者提问：关注到贵公司近年净利率较为稳定，但较早些年有所下滑，且近年毛利率下滑较大，请问贵公司在利润率上有无改善计划或动作？后续是优先做大营业额和扩大市场份额还是有其他打算？华润三九回复：您好，近年来总体毛利率有所下降主要受业务结构影响，2024年公司整体毛利率51.86%。公司围绕发展战略，持续提升核心竞争力，推动高质量发展。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080700036391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","000999","BK0012","BK0185","BK0175","BK0183","BK0028","BK0196","BK0060","BK0010"],"gpt_icon":0},{"id":"2557553203","title":"7月以来股价翻倍，这家药企与华润三九合作布局减重药大单品丨机构调研","url":"https://stock-news.laohu8.com/highlight/detail?id=2557553203","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557553203?lang=zh_cn&edition=full","pubTime":"2025-08-07 17:14","pubTimestamp":1754558049,"startTime":"0","endTime":"0","summary":"摘要7月以来股价翻倍，这家创新药企近日宣布与华润三九就旗下GLP-1产品研发、注册、生产及商业化达成合作，最高可获2.82亿元的研发投入里程碑付款。强强联合下，机构看好公司减重药大单品未来潜力。从调研纪要来看，机构主要关注公司与华润三九、翰宇药业达成的合作情况以及公司Amylin赛道产品进展情况。根据《合作研发协议》，博瑞医药授予华润三九排他性合作开发实施许可及独占性商业化实施许可。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807171709a47a97d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807171709a47a97d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["000999","688166","BK0028","BK0012","BK0175","BK0183","BK0060","BK0185","BK0188","BK0010","BK0196","BK0239"],"gpt_icon":0},{"id":"2557832143","title":"华润三九：公司已持有QHB-196项目的技术成果及知识产权","url":"https://stock-news.laohu8.com/highlight/detail?id=2557832143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557832143?lang=zh_cn&edition=full","pubTime":"2025-08-06 16:48","pubTimestamp":1754470102,"startTime":"0","endTime":"0","summary":"证券之星消息，华润三九(000999)08月06日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！贵公司是否正计划购买沈阳药科大学持有的1类小分子靶向抗肿瘤新药QBH-196项目所有技术成果及知识产权？谢谢！华润三九回复：您好，公司已持有QHB-196项目的技术成果及知识产权，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080600026618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0185","BK0196","BK0175","BK0183","BK0188","BK0239","BK0060","000999","BK0012","BK0028"],"gpt_icon":0},{"id":"2557321435","title":"华润三九：海外业务在公司总体业务中占比较小","url":"https://stock-news.laohu8.com/highlight/detail?id=2557321435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557321435?lang=zh_cn&edition=full","pubTime":"2025-08-06 16:45","pubTimestamp":1754469922,"startTime":"0","endTime":"0","summary":"证券之星消息，华润三九(000999)08月06日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司您好，公司年报显示公司存在少量的海外收入，请问公司自2023年起是否出口欧盟国家华润三九回复：您好，公司海外业务在公司总体业务中占比较小，公司将跟随国家战略，积极探索公司产品向海外推广，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080600026547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000999","BK0196","BK0028","BK0175","BK0188","BK0185","BK0239","BK0010","BK0012","BK0183","BK0060"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1755770854942,"stockEarnings":[{"period":"1week","weight":-0.0377},{"period":"1month","weight":-0.0368},{"period":"3month","weight":-0.0446},{"period":"6month","weight":-0.0444},{"period":"1year","weight":-0.0432},{"period":"ytd","weight":-0.1032}],"compareEarnings":[{"period":"1week","weight":0.0225},{"period":"1month","weight":0.058},{"period":"3month","weight":0.1142},{"period":"6month","weight":0.1146},{"period":"1year","weight":0.3138},{"period":"ytd","weight":0.1237}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华润三九医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"78438人(较上一季度增加3.49%)","perCapita":"21189股","listingDate":"2000-03-09","address":"广东省深圳市龙华区观湖街道观澜高新园区观清路1号","registeredCapital":"166958万元","survey":" 华润三九医药股份有限公司的主营业务是高质量医药健康产品创新研发和智能制造。公司的主要产品是CHC健康消费品、处方药。报告期内，公司获得中国质量协会QC成果发表赛一等奖。","listedPrice":8.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润三九(000999)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润三九(000999)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润三九,000999,华润三九股票,华润三九股票老虎,华润三九股票老虎国际,华润三九行情,华润三九股票行情,华润三九股价,华润三九股市,华润三九股票价格,华润三九股票交易,华润三九股票购买,华润三九股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润三九(000999)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润三九(000999)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}